TransMedics Group, Inc. (TMDX) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2026-07-15

TransMedics Group, Inc. (TMDX) has filed 12 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-15. 2 Form 8-K material event filings were reported by TMDX in the last 90 days. 1 Form 144 notices of proposed sale were filed for TMDX stock. InsiderAlpha tracks every TMDX SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About TransMedics Group, Inc. (TMDX)

SEC CIK	0001756262

90-Day SEC Filing Activity

Form 4 filings (90d)	12
Form 8-K filings (90d)	2
Form 144 notices (90d)	1
Latest Form 4 filing	2026-07-15

Recent TMDX Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2026-07-10	Hernandez Gerardo	Chief Financial Officer	A — Grant or award	17.2K	$0.00	—	SEC
2026-07-10	Hassanein Waleed H	President & CEO	A — Grant or award	49.7K	$0.00	—	SEC
2026-07-10	Corcoran Nicholas	See remarks	A — Grant or award	11.7K	$0.00	—	SEC
2026-06-15	Gunderson Thomas J.	Insider	M — Option exercise	19.3K	$2.21	$43K	SEC
2026-06-15	Gunderson Thomas J.	Insider	S — Open-market sale	9.6K	$75.06	$722K	SEC
2026-05-20	Weill David	Insider	A — Grant or award	2.9K	$0.00	—	SEC
2026-05-20	RAINES MERILEE	Insider	A — Grant or award	2.9K	$0.00	—	SEC
2026-05-20	Basile Edward M	Insider	A — Grant or award	2.9K	$0.00	—	SEC
2026-05-20	Lovell Stephanie	Insider	A — Grant or award	2.9K	$0.00	—	SEC
2026-05-20	KANIA EDWIN M JR	Insider	A — Grant or award	2.9K	$0.00	—	SEC
2026-05-20	Gunderson Thomas J.	Insider	A — Grant or award	2.9K	$0.00	—	SEC
2026-05-20	TOBIN JAMES R	Insider	A — Grant or award	2.9K	$0.00	—	SEC
2026-05-19	Forsyth Matthew S.	See Remarks	A — Grant or award	15.4K	$0.00	—	SEC
2026-03-04	Weill David	Insider	M — Option exercise	3.6K	$14.20	$51K	SEC
2026-03-04	Weill David	Insider	S — Open-market sale	3.6K	$146.82	$524K	SEC

All transactions sourced from SEC EDGAR Form 4 filings for TransMedics Group, Inc. (TMDX). Updated in real time as new filings are submitted to the SEC.

Most-Active TMDX Insiders — Last 90 Days

Insider	Form 4 filings	Total transaction value
Gunderson Thomas J.	4	$765K
Corcoran Nicholas	2	—
Hassanein Waleed H	2	—
Hernandez Gerardo	2	—
Forsyth Matthew S.	2	—

Recent TMDX Form 8-K Material Events

2026-05-21 — Item 5.07, 9.01 [SEC]
2026-05-05 — Item 2.02, 9.01 [SEC]
2026-02-27 — Item 2.02, 9.01 · Earnings · neutral [SEC]
TransMedics announced additional information regarding the release of a U.S. valuation allowance on deferred tax assets (DTAs) for Q4 2025, which impacts previously reported financial results. This is a non-cash accounting adjustment related to tax position changes, not an operat
2026-02-24 — Item 2.02, 9.01 · Earnings · neutral [SEC]
TransMedics Group issued a press release on February 24, 2026 announcing its financial results for Q4 2025 and full year 2025. This is a routine quarterly earnings disclosure filed via 8-K Item 2.02 (Results of Operations and Financial Condition). The actual substance and materia

Recent TMDX Form 144 Notices of Proposed Sale

2026-06-15 — — [SEC]

Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.

Recent Insider Filings

2026-07-15 — Corcoran Nicholas (See remarks)
2026-07-15 — Hernandez Gerardo (Chief Financial Officer)
2026-07-15 — Hassanein Waleed H (President & CEO)
2026-06-17 — Gunderson Thomas J. (Insider)
2026-05-22 — Lovell Stephanie (Insider)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in TMDX insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

TMDX Insider Trading — FAQ

What is the latest insider trade for TMDX?: TransMedics Group, Inc. (TMDX) had 12 insider filings in the last 90 days, with the most recent on 2026-07-15. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying TMDX stock?: 0 insider purchases of TMDX were filed in the last 90 days.
How many insiders are selling TMDX stock?: 0 insider sales of TMDX were filed in the last 90 days.
Where can I see TMDX SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every TMDX SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live TMDX dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.